Journal
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
Volume 8, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fcell.2020.584590
Keywords
p57(Kip2); CDK inhibitor; cell cycle; development; transcription; stem cells; CDKN1C
Categories
Funding
- Ligue Nationale Contre le Cancer
- Fondation ARC pour la Recherche sur le Cancer
- FRM Equipes grant from the Fondation pour la Recherche Medicale [DEQ20170336707]
Ask authors/readers for more resources
The cyclin/CDK inhibitor p57(Kip2)belongs to the Cip/Kip family, with p21(Cip1)and p27(Kip1), and is the least studied member of the family. Unlike the other family members, p57(Kip2)has a unique role during embryogenesis and is the only CDK inhibitor required for embryonic development. p57(Kip2)is encoded by the imprinted geneCDKN1C, which is the gene most frequently silenced or mutated in the genetic disorder Beckwith-Wiedemann syndrome (BWS), characterized by multiple developmental anomalies. Although initially identified as a cell cycle inhibitor based on its homology to other Cip/Kip family proteins, multiple novel functions have been ascribed to p57(Kip2)in recent years that participate in the control of various cellular processes, including apoptosis, migration and transcription. Here, we will review our current knowledge on p57(Kip2)structure, regulation, and its diverse functions during development and homeostasis, as well as its potential implication in the development of various pathologies, including cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available